| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.50B | 2.56B | 2.63B | 2.66B | 1.88B | 1.25B |
| Gross Profit | 1.64B | 1.69B | 1.72B | 1.71B | 1.25B | 815.30M |
| EBITDA | 721.90M | 456.60M | -10.50M | -3.01B | 532.15M | 61.80M |
| Net Income | -396.00M | -636.70M | -911.20M | -3.96B | -270.50M | -350.60M |
Balance Sheet | ||||||
| Total Assets | 11.23B | 11.49B | 12.71B | 13.94B | 20.18B | 14.79B |
| Cash, Cash Equivalents and Short-Term Investments | 318.70M | 295.20M | 370.70M | 348.80M | 587.61M | 257.73M |
| Total Debt | 4.48B | 4.59B | 4.81B | 5.10B | 5.61B | 3.63B |
| Total Liabilities | 6.32B | 6.35B | 6.71B | 7.13B | 8.26B | 5.76B |
| Stockholders Equity | 4.90B | 5.14B | 5.99B | 6.81B | 11.93B | 9.03B |
Cash Flow | ||||||
| Free Cash Flow | 335.20M | 357.50M | 501.70M | 306.40M | 205.30M | 155.80M |
| Operating Cash Flow | 609.90M | 646.60M | 744.20M | 509.30M | 323.80M | 263.50M |
| Investing Cash Flow | -171.10M | -236.70M | -237.40M | 57.30M | -4.04B | -2.99B |
| Financing Cash Flow | -504.80M | -470.10M | -496.50M | -759.20M | 4.03B | 2.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $37.51B | 18.01 | 14.50% | 1.60% | 7.44% | -4.57% | |
78 Outperform | $7.60B | 14.20 | 22.32% | 1.50% | 7.40% | -14.45% | |
74 Outperform | $10.33B | 28.54 | 10.21% | ― | 14.26% | -15.49% | |
71 Outperform | $6.31B | 26.91 | 25.96% | ― | 14.43% | 29.86% | |
69 Neutral | $16.78B | 20.41 | 109.26% | ― | 5.24% | -16.05% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
49 Neutral | $2.49B | ― | -7.60% | ― | -2.96% | 71.30% |
Clarivate Plc is a leading global provider of transformative intelligence, offering enriched data, insights, analytics, workflow solutions, and expert services in the areas of Academia & Government, Intellectual Property, and Life Sciences & Healthcare.
Clarivate Plc’s recent earnings call revealed a cautious optimism, as the company reported improvements in contract value and renewal rates, alongside robust financial management through debt reduction and share repurchases. Despite these positive strides, challenges persist in revenue growth and profitability, particularly within the Intellectual Property segment. The company’s strategic focus on AI and product innovation highlights potential avenues for future growth.
On October 29, 2025, Clarivate reported its third-quarter results, highlighting improved financial and operational performance. The company raised its 2025 revenue outlook and reported a net loss reduction compared to the previous year. Despite a slight decrease in organic revenues, Clarivate saw growth in organic ACV and an improvement in the mix of organic recurring revenue. The company repurchased 11.7 million ordinary shares and repaid $100 million of debt in the third quarter, demonstrating a commitment to shareholder value.
The most recent analyst rating on (CLVT) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on Clarivate stock, see the CLVT Stock Forecast page.